Tm2d1-flox Mouse

Tm2d1, also known as β -amyloid peptide binding protein, is involved in important biological processes. It is critical to the pathogenesis of Alzheimer's disease and has potential connections with cancer-related processes [1,4,5].

In hepatocellular carcinoma (HCC), TM2D1 is increasingly expressed in tumors relative to peritumoral tissues. Overexpression of TM2D1 induces HCC cell proliferation, migration, and invasion, related to epithelial-mesenchymal transition (EMT), by promoting Akt and β-catenin hyper-activation. Depletion of TM2D1 leads to the opposite phenotype [1].

In colorectal cancer, sevoflurane and propofol co-treatment exerts anti-tumor activities, and TM2D1 is considered a target of these anesthetics. Overexpression of TM2D1 reverses the anti-tumor effects of sevoflurane and propofol on colorectal cancer cell biology behaviors [2].

In cattle and buffalo preantral follicles, the expression of TM2D1 was detected in the study of genes associated with apoptosis, indicating its possible role in follicular development [3].

In conclusion, TM2D1 plays important roles in cancer-related biological processes such as cell proliferation, migration, invasion, and EMT, as well as in follicular development. The findings from studies on TM2D1 contribute to understanding the mechanisms of these diseases and biological processes, potentially providing new therapeutic targets for cancer treatment.